Skip to content

A Prospective Evaluation of the Catheter Science C3 Umbrella Catheter.

A Prospective Evaluation of the Catheter Science C3 Umbrella Catheter for Patients With Urinary Retention Due to Bladder Dysfunction (C3 Catheter Study)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03353571
Enrollment
50
Registered
2017-11-27
Start date
2017-08-31
Completion date
2018-03-31
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intermittent Catheterization, Urinary Bladder, Neurogenic, Urinary Retention

Brief summary

The Catheter Science C3 Umbrella Catheter has been developed for management of urinary retention in patients who are either using a Foley or Self Intermittent Catheter. This device is inserted into the bladder in an extended state and once the stylet is removed the device folds into collapsed state. A thread is attached to the device and traverses thru the urethra and is attached to a bobber. With gentle traction on the thread the device engages the bladder neck and the central tube extends which allows for the flow of urine. Once voiding is complete, the thread is released and the device collapses back to the folded state into the bladder. Each voiding cycle is accomplished in a similar fashion. This is a novel technique in which the bladder is catheterized with the device from within the bladder into the bladder neck and urethra. The standard self catheter technique is for placement of a catheter from the outside into the urethra and into the bladder.

Detailed description

Interventional (clinical trial): Participants are assigned prospectively to an intervention or interventions according to a protocol to evaluate the effect of the intervention(s) on biomedical or other health related outcomes. This single arm, prospective study is designed to produce valid scientific evidence regarding: 1. Safety and efficacy of the Catheter Science C3 Umbrella Catheter in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days. 2. The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) A single arm study design was chosen because there is no alternative treatment to serve as an appropriate control. The C3 catheterizes the bladder with engagement into the bladder neck under the control of the patient or care giver. A Foley catheter, a pre- amendment device, was considered for a control treatment. However, although a Foley catheter is used to establish urinary drainage with close to 100% efficacy, it does not restore voiding function like the C3, and severely impairs activities of daily life. The intrinsic design flaws of a Foley catheter traversing thru the urinary passage which violates the anatomical protective points which help to avoid bacterial contamination. The distal 1/3 portion of the urethra in females is commonly colonized with bacteria. Standard Catheter technique traverses from the outside into the entire length of the urethra to drain the bladder. The standard self catheter flow characteristics are impacted due to the placements of the eyes to the catheter lumen. The C3 lumen is open in line with the flow.

Interventions

DEVICEC3 UMBRELLA CATHETER

The C3 is an alternative method to facilitate bladder drainage in the study population which are using either a foley catheter or Clean Intermittent Catheter technique to drain the bladder.

Sponsors

Dr. Gaines W. Hammond Jr. MD FACS
Lead SponsorINDIV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Safety and efficacy of the Catheter Science C3 Umbrella Catheter in establishing urinary drainage and allowing the control of micturition when indwelling for up to 7 days. The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) A single arm study design was chosen because there is no alternative treatment to serve as an appropriate control. The C3 catheterizes the bladder with engagement into the bladder neck under the control of the patient or care giver. A Foley catheter, a pre- amendment device, was considered for a control treatment. However, although a Foley catheter is used to establish urinary drainage with close to 100% efficacy, it does not restore voiding function like the C3, and severely impairs activities of daily life.

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patients with Bladder Dysfunction requiring mechanical drainage. 2. Patients with actual urinary retention

Exclusion criteria

1. Inability to undergo bladder catheterization (e.g., urethral stricture or history of urethral stricture) 2. Gross hematuria

Design outcomes

Primary

MeasureTime frameDescription
Catheterization of the bladder from an antegrade direction with the C3 device.Measurement of data points are collected sequentially every 7 days up to 28 days.The percentage for patients enrolled in the student with the C3 inserted who are able to engage the tubular portion of the device into the bladder neck and urethra from the default position in the bladder with resultant drainage of the bladdder.
The retreat of the C3 back into the bladder from the engaged positionMeasurement of data points are collected sequentially every 7 days up to 28 days.The percentage of enrolled patients who upon completion of bladder drainage with the engaged tubular portion of the C3 in bladder neck and urethral location retreats back into the default position in the bladder.

Secondary

MeasureTime frameDescription
Reduction in Catheter Acquired Urinary Tract Infection RateMeasurement of data points are collected sequentially every 7 days up to 28 days.The reduction in Catheter Acquired Urinary Tract Infection (CAUTI) with the C3 Umbrella Catheter as compared to the expected incidence with either a Foley Catheter or Self Intermittent Catheter for bladder drainage.

Countries

United States

Contacts

Primary ContactGAINES W HAMMOND, MD
GHAMMOND@WATSONCLINIC.COM863-680-7300
Backup ContactELAYNE HALL
EHALL@WATSONCLINIC.COM863-680-7300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026